Taysha Gene Therapies Inc

NASDAQ:TSHA  
19.93
-1.02 (-4.87%)
Earnings Announcements

Taysha Gene Therapies Q2 Loss Per Share Of $1.09

Published: 08/16/2021 11:45 GMT
Taysha Gene Therapies Inc (TSHA) - Taysha Gene Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update.
Q2 Loss per Share $1.09.
Raisio Oyj - As of June 30, 2021, Taysha Had $197.4 Million in Cash and Cash Equivalents.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.08

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.14

More details on our Analysts Page.